Loading...
XASEAMS
Market cap20mUSD
Dec 23, Last price  
3.26USD
1D
-1.93%
1Q
7.46%
Jan 2017
-2.81%
Name

American Shared Hospital Services

Chart & Performance

D1W1MN
XASE:AMS chart
P/E
34.27
P/S
0.98
EPS
0.10
Div Yield, %
0.00%
Shrs. gr., 5y
1.22%
Rev. gr., 5y
1.58%
Revenues
21m
+8.00%
16,389,00018,231,00020,385,00022,622,00019,099,00016,768,00016,675,00022,221,00017,048,00017,584,00015,417,00016,548,00018,700,00019,556,00019,714,00020,605,00017,837,00017,628,00019,746,00021,325,000
Net income
610k
-54.07%
1,985,0001,767,0001,656,000951,000477,000-188,00057,000506,00038,000-312,000-952,000-1,522,000930,0001,923,0001,023,0001,430,000-7,716,000678,0001,328,000610,000
CFO
6m
-20.97%
7,608,0008,480,0009,164,0008,484,0008,947,0007,704,0007,184,0006,823,0006,871,0008,076,0006,773,0008,548,0008,378,0007,853,0008,062,0008,047,0009,745,0006,267,0007,235,0005,718,000
Dividend
Jun 28, 20070.0475 USD/sh
Earnings
Mar 25, 2025

Profile

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
URL
https://ashs.com/
IPO date
Jul 04, 1984
Employees
28
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
21,325
8.00%
19,746
12.01%
17,628
-1.17%
Cost of revenue
6,908
11,364
10,902
Unusual Expense (Income)
NOPBT
14,417
8,382
6,726
NOPBT Margin
67.61%
42.45%
38.16%
Operating Taxes
431
963
269
Tax Rate
2.99%
11.49%
4.00%
NOPAT
13,986
7,419
6,457
Net income
610
-54.07%
1,328
95.87%
678
-108.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
5
5
BB yield
-0.03%
-0.03%
Debt
Debt current
4,641
2,051
1,450
Long-term debt
11,098
12,615
15,410
Deferred revenue
70
140
Other long-term liabilities
63
4,000
Net debt
2,049
2,213
486,597
Cash flow
Cash from operating activities
5,718
7,235
6,267
CAPEX
(6,273)
(388)
(1,674)
Cash from investing activities
(6,273)
(388)
(1,674)
Cash from financing activities
1,910
(2,657)
(655)
FCF
11,932
11,780
8,386
Balance
Cash
13,690
12,453
8,263
Long term investments
(478,000)
Excess cash
12,624
11,466
Stockholders' equity
18,047
17,782
16,795
Invested Capital
30,626
28,289
40,415
ROIC
47.48%
21.60%
16.49%
ROCE
33.33%
20.66%
16.45%
EV
Common stock shares outstanding
6,393
6,303
6,059
Price
2.38
-18.79%
2.93
23.63%
2.37
6.76%
Market cap
15,212
-17.63%
18,468
28.61%
14,360
4.63%
EV
20,916
24,681
505,303
EBITDA
19,582
13,165
11,698
EV/EBITDA
1.07
1.87
43.20
Interest
1,112
806
739
Interest/NOPBT
7.71%
9.62%
10.99%